下一代抗菌冷凝:贝贝林注入的智能膜,具有分子对接引导的MRSA和MDR大肠杆菌向向
Metin Yildirim1, Mehmet Cimentepe2, Kemal Dogan3
1Department of Biochemistry, Faculty of Pharmacy, Harran University, Sanliurfa, Türkiye.
Biophysical chemistry
|June 24, 2025
概括
含有柏柏林的聚二乙基甲酸 (pHEMA) 冰凝膜对MRSA和大肠杆菌等多抗药性 (MDR) 细菌具有强大的抗菌活性. 这些生物相容膜有效抑制细菌生长并破坏生物膜,为伤口愈合应用提供了有前途的解决方案.
科学领域:
- 生物材料科学 生物材料科学
- 微生物学 微生物学
- 药物运输 药物运输 药物运输
背景情况:
- 多抗药性 (MDR) 细菌对全球健康构成重大威胁,推动了对新型抗菌战略的需求.
- 柏柏林是一种天然类化合物,具有抗菌性质,但具有较差的水溶性,限制了其治疗用途.
- 聚二乙基甲酸 (pHEMA) 冰凝是适用于生物医学应用的生物相容材料,包括伤口愈合.
研究的目的:
- 开发和表征含柏柏林的pHEMA冷凝膜,以提高抗菌功效.
- 评估这些新型膜对MDR病原体的生物相容性和抗菌活性.
- 为了研究贝贝林在冷凝矩阵中的抗菌作用背后的分子机制.
主要方法:
- 柏柏林被纳入了pHEMA的冷凝膜,随后使用FT-IR光谱学进行了表征.
- 通过MTT测定,使用L929纤维细胞评估生物相容性.
- 针对MDR大肠杆菌和MRSA的抗菌疗效通过磁盘扩散和时间杀死测试来确定,并补充了用于抗菌膜分析的SEM成像.
- 对关键细菌蛋白进行了分子对接研究,以阐明相互作用机制.
主要成果:
- 装有柏柏林的pHEMA冷凝膜表现出极好的生物相容性,细胞活力超过88%.
- 高剂量的柏柏林载荷膜 (BM2) 实现了显著的抑制率:87.2%对MRSA和96.8%对MDR E. coli.
- SEM成像证实了细菌生物膜被贝贝林载荷的膜破坏.
- 分子对接揭示了柏柏林与细菌点之间的强烈相互作用,特别是与大肠杆菌DNA旋转酶B (PDB ID: 6KZX) 的 -7.898 kcal/mol.
结论:
- 装有柏林的pHEMA冷凝膜代表了一个有前途的抗菌平台,具有良好的生物相容性和对MDR细菌的强效.
- 这些材料显示出先进的伤口愈合应用的潜力,解决了抗菌素耐药性的挑战.
- 该研究提供了对作用机制的见解,支持开发基于柏柏林的抗菌疗法.
相关概念视频
01:18Surface Membrane Barriers
3.0K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
3.0K
01:25Mechanism of Antibiotic Resistance in MRSA
245
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
245
01:23Inhibitors of Gram-positive Cell Wall Synthesis
216
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
216
01:25Clinical Significance of Antibiotic Resistance
106
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
106